Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
about
Omega-3 fatty acids and depression: scientific evidence and biological mechanismsCircadian rhythm hypotheses of mixed features, antidepressant treatment resistance, and manic switching in bipolar disorderStress risk factors and stress-related pathology: neuroplasticity, epigenetics and endophenotypesGlucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsCytokines sing the blues: inflammation and the pathogenesis of depressionEnvironment and schizophrenia: environmental factors in schizophrenia: childhood trauma--a critical reviewStress-Related Immune Markers in Depression: Implications for TreatmentComorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerationsN-3 (omega-3) polyunsaturated Fatty acids in the pathophysiology and treatment of depression: pre-clinical evidencePsychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behaviorRole of NG2 expressing cells in addiction: a new approach for an old problemNeuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depressionInvited review: the evolution of antidepressant mechanismsAntidepressant-Like Effects of Lindera obtusiloba Extracts on the Immobility Behavior of Rats in the Forced Swim TestAssociation analysis of the chromosome 4p-located G protein-coupled receptor 78 (GPR78) gene in bipolar affective disorder and schizophreniaNew approaches to antidepressant drug discovery: beyond monoaminesPolymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentAntidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transportersBlood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorderInflammation and its discontents: the role of cytokines in the pathophysiology of major depressionChronic stress and brain plasticity: Mechanisms underlying adaptive and maladaptive changes and implications for stress-related CNS disordersAlterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis by gene targeting in mice.Chronic subordinate colony housing paradigm: a mouse model to characterize the consequences of insufficient glucocorticoid signaling.Puberty and adolescence as a time of vulnerability to stressors that alter neurobehavioral processes.Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patientsGlucocorticoid receptor dysfunction: consequences for the pathophysiology and treatment of mood disorders.Depression and immunity: a role for T cells?Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brainHypothalamic-pituitary-adrenal axis dysregulation and behavioral analysis of mouse mutants with altered glucocorticoid or mineralocorticoid receptor functionComorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.Role of prefrontal cortex glucocorticoid receptors in stress and emotionAll-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.Coexisting chronic conditions associated with mortality and morbidity in adult patients with asthma.Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk.RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionCellular mechanisms underlying affective resiliency: the role of glucocorticoid receptor- and mitochondrially-mediated plasticity.
P2860
Q21284717-CF1610D4-8346-4EA3-926B-6A6ED6B0CE33Q22241088-DD0B1DDC-1345-4FEA-8C0D-B61F636D5BCBQ22305696-CB7A6FD9-94E3-47D0-A09C-854AFF1FFFC9Q24618470-9037B4CF-86B5-4B35-AB75-44C754EAFDAEQ24633065-0856D503-D46A-47A6-AC45-83E682731880Q24644216-ED8A9013-71A3-4B19-BD87-1ED286B6E2DAQ26771607-82309FF2-3828-4076-8AB6-07AB527DFFA3Q26798238-C7DB51B4-4FB4-46E6-BB95-D260551FD3A6Q26849307-A7F8F409-8462-4AEE-8142-2D3A69242CBAQ27694728-398886F7-3443-49BD-9EEE-2E294634521EQ28082885-DEFF2252-D2A4-4B1A-A1AB-0F770496BCEBQ28220405-645167E9-860C-41B2-BEA7-93D38BD0F7AEQ28241221-126D8B01-70C3-4218-BF60-296D4A8D9E1BQ28273762-2DCAA058-9C2B-4FA4-BEAD-6C15C459E067Q28289500-153E72FD-40E9-4494-AF98-0132B76AC036Q28293089-FEF75AE6-504A-48D7-86CD-76C1DCB93FC4Q28295248-88011F6A-3F82-4804-AA45-A177C3A6D9E6Q28363795-296B0F91-EDD4-4194-8266-DD116DD56835Q28480601-039080A2-0F5B-41CF-A51C-DD17A7BDA25AQ29617326-71271542-429E-4CBB-8A9A-16318A8E78E3Q30371216-F449F646-A36F-4E0F-9A22-CF5312FA87B6Q30372214-4D59FC01-3750-41FC-803B-3F01B3C7271EQ30394714-63BF489D-C541-4700-8F5C-19A7955C50D3Q30417042-1BFBC7EA-216D-4FD3-8AC1-4C52723AA915Q30421733-DC9CC687-7697-4284-99B2-A07B1642C4E5Q30454937-6DFC0517-17FB-46FB-A05D-FCC602886A2FQ30455078-9B445C5F-F714-4494-9398-886B0878FFD9Q30477689-F7A3D909-6283-4594-B05D-59C3542BD935Q30477752-C529EDD2-49FB-4FF3-BB5C-E75DDBFAA75CQ30481500-16354E65-7A83-4A3B-A25E-8EF207408308Q30486661-1CEB9BFF-445C-4A88-9523-D75B629183ABQ30493038-77CD742E-6CF0-4842-A084-8BA61CB71B1EQ30551061-A7DA22B8-2E56-4ED9-A06D-94ED663CE495Q30578605-D0CB312C-08C7-4D0A-A96F-9D4788B1637EQ30581306-21EB428D-9C0B-4468-AAA5-B4845D5C16D7Q30650490-0073FDF8-E3D7-4F3E-9DFC-A887769A921DQ30988305-2D9FC6BA-7D49-4BB1-A2C4-9A6B39F7816BQ33402443-C2EB3897-3703-4B8E-B094-D6221E7B9CDCQ33403748-C2CABE80-74AE-4220-8427-7009477D9329Q33583969-07BC8643-E6FE-4EE1-95D4-7D5D57A0BF1A
P2860
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@ast
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@en
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@nl
type
label
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@ast
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@en
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@nl
prefLabel
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@ast
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@en
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@nl
P1476
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
@en
P2093
Pariante CM
P304
P356
10.1016/S0006-3223(00)01088-X
P407
P577
2001-03-01T00:00:00Z